Increasing Access to Affordable Drugs

Illinois hospitals are keeping the promise of 340B, investing savings from the federal drug discount program in patients, while pharmaceutical companies are limiting access to lifesaving medications.

Support Access to Affordable Drugs

IHA has developed key resources that, along with the hospital stories below, show how important the 340B drug discount program is to patients who cannot afford needed medications. See our infographic and fact sheet to learn more about the federal program and why the restrictions imposed by pharmaceutical companies are harming patients.

Drug Prices are Rising

$200k For the first time in history, median price of a new drug exceeded $200,000
36.9% Drug cost increase from 2019 to 2021
Feb 01, 2024

Ascension Illinois

Every year, Ascension Illinois hospitals reduce out-of-pocket costs for patients on high-cost specialty medications by over $1 million. Those savings and other programs are now at risk.

Feb 01, 2024

Carle Health

Since pharmaceutical companies began restricting 340B contract pharmacies, Carle Health has seen its volume of 340B-priced prescriptions dwindle to almost nothing, jeopardizing access to care.

Feb 01, 2024

Ferrell Hospital

A 75% drop in federal 340B drug discount savings has forced Ferrell Hospital to considering pulling back on services such as mammography and new offerings, due to drugmaker restrictions.

Feb 01, 2024

Franciscan Health Olympia Fields

A vital lifeline for hospitals serving low-income communities, the 340B drug discount program has resulted in savings that Franciscan Health Olympia Fields invested in patient services.

Feb 01, 2024

Graham Health System

With savings from the 340B drug discount program, Graham Health System operates three health clinics that otherwise wouldn’t exist. Program restrictions by drugmakers could impact those clinics.

Feb 01, 2024

Hammond-Henry Hospital

With funding from the 340B drug discount program, Hammond-Henry Hospital can offer free injury screening, long-term care and more to the community. Those services, though, are at risk.

Feb 01, 2024

Memorial Hospital, Chester

In just three years, Memorial Hospital saw a 52% decrease in 340B drug cost savings for hospital patient use and is projecting an 86% decrease for fiscal year 2024 in the contract pharmacy program.

Feb 01, 2024

OSF HealthCare

Eleven of OSF HealthCare’s 16 hospitals participate in the 340B drug discount program, designed to help hospitals increase access to care for low-income patients and underserved communities.

Feb 01, 2024

Pinckneyville Community Hospital

Located in a city of 5,005 people, Pinckneyville Community Hospital is a lifeline to rural communities. Yet, drug company limits on 340B contract pharmacies are causing big financial concern.

Feb 01, 2024

Sinai Chicago

Serving Chicago’s West and Southwest sides, Sinai Chicago has invested 340B drug discount savings to expand healthcare services. The safety net provider says reduced savings will harm its efforts.

Feb 01, 2024

Southern Illinois Healthcare (SIH)

Serving high-poverty communities, SIH has used savings and revenue from the 340B drug discount program to expand cancer care and access to medication assistance programs.

Feb 01, 2024

Sparta Community Hospital

With savings from the 340B drug discount program, Sparta Community Hospital has hired additional clinicians for its rural health clinics, resulting in a 21% increase in patient visits over 10 years.

Feb 01, 2024

UW Health

An expected 10% reduction in 340B drug savings would leave UW Health’s Illinois hospitals with $3.5 million less to spend on patient services. Most Illinois system patients lack private insurance.